TY  - RPRT
TI  - Technology evaluation: bevacizumab, Genentech/Roche.
AU  - Michael L Salgaller
PY  - 2003
UR  - https://pubmed.ncbi.nlm.nih.gov/14755893/
ID  - 14755893
ER  -